SU545244A3 - Зоотехнический состав - Google Patents
Зоотехнический составInfo
- Publication number
- SU545244A3 SU545244A3 SU1916394A SU1916394A SU545244A3 SU 545244 A3 SU545244 A3 SU 545244A3 SU 1916394 A SU1916394 A SU 1916394A SU 1916394 A SU1916394 A SU 1916394A SU 545244 A3 SU545244 A3 SU 545244A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- animals
- composition
- drug
- injected
- oxo
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title description 9
- 241001465754 Metazoa Species 0.000 description 18
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
- 229960005309 estradiol Drugs 0.000 description 5
- 229930182833 estradiol Natural products 0.000 description 5
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 4
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 4
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 4
- 229960004544 cortisone Drugs 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 206010054949 Metaplasia Diseases 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- -1 cortisone steroids Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000015689 metaplastic ossification Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 2
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229960003657 dexamethasone acetate Drugs 0.000 description 2
- 238000001647 drug administration Methods 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000186 progesterone Substances 0.000 description 2
- 229960003387 progesterone Drugs 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 229940080313 sodium starch Drugs 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- FPVRUILUEYSIMD-RPRRAYFGSA-N [(8s,9r,10s,11s,13s,14s,16r,17r)-9-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] acetate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(OC(C)=O)[C@@]1(C)C[C@@H]2O FPVRUILUEYSIMD-RPRRAYFGSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Chemical group C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000012381 commercial assessment Methods 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- KNFXXAGQEUUZAZ-UHFFFAOYSA-N ethyl ethaneperoxoate Chemical compound CCOOC(C)=O KNFXXAGQEUUZAZ-UHFFFAOYSA-N 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 231100000508 hormonal effect Toxicity 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- JUHDUIDUEUEQND-UHFFFAOYSA-N methylium Chemical compound [CH3+] JUHDUIDUEUEQND-UHFFFAOYSA-N 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/168—Steroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/184—Hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7216665A FR2183555B1 (OSRAM) | 1972-05-10 | 1972-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU545244A3 true SU545244A3 (ru) | 1977-01-30 |
Family
ID=9098276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU1916394A SU545244A3 (ru) | 1972-05-10 | 1973-05-08 | Зоотехнический состав |
Country Status (9)
| Country | Link |
|---|---|
| JP (1) | JPS6017770B2 (OSRAM) |
| CA (1) | CA1001072A (OSRAM) |
| DE (1) | DE2323615A1 (OSRAM) |
| DK (1) | DK156539C (OSRAM) |
| FR (1) | FR2183555B1 (OSRAM) |
| GB (1) | GB1420831A (OSRAM) |
| IE (1) | IE37621B1 (OSRAM) |
| NL (1) | NL180276C (OSRAM) |
| SU (1) | SU545244A3 (OSRAM) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2248029B1 (OSRAM) * | 1973-10-19 | 1977-03-11 | Roussel Uclaf | |
| FR2388560A1 (fr) * | 1977-04-27 | 1978-11-24 | Roussel Uclaf | Nouvelles compositions zootechniques renfermant d'une part le zeranol et d'autre part un steroide 4,9,11 trienique |
| JPS54145819A (en) * | 1978-05-04 | 1979-11-14 | Nippon Denso Co Ltd | Engine control |
| DE10305811A1 (de) | 2003-02-12 | 2004-08-26 | Ethicon Gmbh | Chirurgisches Implantat |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA889253A (en) * | 1971-12-28 | E. Jordan Charles | Method of finishing swine for market | |
| DE1047596B (de) * | 1956-12-31 | 1958-12-24 | Olin Mathieson | Hormonpraeparat zur Aufzucht und zum Maesten von Rindvieh und Schafen |
| NL126395C (OSRAM) * | 1962-03-06 | |||
| FR1380414A (fr) * | 1962-04-20 | 1964-12-04 | Roussel Uclaf | Nouveaux stéroïdes estratriènes et procédé de préparation |
| NL124139C (OSRAM) * | 1964-11-04 | |||
| FR5301M (OSRAM) * | 1966-01-21 | 1967-08-16 | ||
| CA919594A (en) * | 1966-03-02 | 1973-01-23 | C. Bachman Marvin | Composition |
| FR5519M (OSRAM) * | 1966-06-07 | 1967-11-06 |
-
1972
- 1972-05-10 FR FR7216665A patent/FR2183555B1/fr not_active Expired
-
1973
- 1973-05-08 SU SU1916394A patent/SU545244A3/ru active
- 1973-05-08 CA CA170,704A patent/CA1001072A/en not_active Expired
- 1973-05-09 NL NLAANVRAGE7306463,A patent/NL180276C/xx not_active IP Right Cessation
- 1973-05-10 DK DK257673A patent/DK156539C/da not_active IP Right Cessation
- 1973-05-10 DE DE2323615A patent/DE2323615A1/de active Granted
- 1973-05-10 JP JP48051246A patent/JPS6017770B2/ja not_active Expired
- 1973-05-10 GB GB2231873A patent/GB1420831A/en not_active Expired
- 1973-05-10 IE IE743/73A patent/IE37621B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL180276C (nl) | 1987-02-02 |
| GB1420831A (en) | 1976-01-14 |
| JPS6017770B2 (ja) | 1985-05-07 |
| IE37621B1 (en) | 1977-08-31 |
| CA1001072A (en) | 1976-12-07 |
| DK156539B (da) | 1989-09-11 |
| DE2323615A1 (de) | 1973-11-22 |
| AU5548273A (en) | 1974-11-14 |
| IE37621L (en) | 1973-11-10 |
| NL7306463A (OSRAM) | 1973-11-13 |
| JPS4947515A (OSRAM) | 1974-05-08 |
| FR2183555B1 (OSRAM) | 1975-06-20 |
| FR2183555A1 (OSRAM) | 1973-12-21 |
| DK156539C (da) | 1990-01-29 |
| NL180276B (nl) | 1986-09-01 |
| DE2323615C2 (OSRAM) | 1987-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Luisi et al. | Double-blind group comparative study of testosterone undecanoate and mesterolone in hypogonadal male patients | |
| CA2267743C (en) | Low dose estrogen interrupted hormone replacement therapy | |
| Nelson | Some factors involved in the control of the gametogenic and endocrine functions of the testis | |
| Joshi et al. | Synergistic effects of testosterone and oestrogens on accessory sex glands and sexual behaviour of the boar | |
| Bilbey et al. | Effect of various natural steroids on the phagocytic activity of the reticulo-endothelial system | |
| SU545244A3 (ru) | Зоотехнический состав | |
| Jabara | Some tissue changes in the dog following stilboestrol administration | |
| Lev-Ran | Secondary amenorrhea resulting from uncontrolled weight-reducing diets | |
| DE69027028T2 (de) | Als männliches kontrazeptikum verwendbare zusammensetzungen | |
| Kochakian | Renotrophic-androgenic and somatotrophic properties of further steroids | |
| Gabrilove et al. | Persistent gynecomastia resulting from scalp inunction of estradiol: a model for persistent gynecomastia | |
| CN107007611A (zh) | 醋酸诺美孕酮在制备治疗子宫内膜癌的药物中的应用 | |
| EP2133082B1 (en) | THE USE OF GINSENOSIDE Rg1, ITS METABOLITES GINSENOSIDE Rh1 AND/OR PpT | |
| HOWARD et al. | The effects of ovariectomy and administration of progesterone on the adrenal X-zone and the uterus | |
| Nieschlag et al. | The Cultural and Medical History of the Testes and Testosterone: From Antiquity to Modern Times | |
| Tewari et al. | Antifertility effect of betal leaf stalk (Tambul patrabrint): a preliminary experimental study | |
| International Planned Parenthood Federation IPPF | Statement on injectable contraception | |
| Hudson | Natural progesterone: Clinical indications in women's health | |
| Biskind | The relation of nutritional deficiency to impaired libido and potency in the male | |
| Nieschlag et al. | The Cultural and Medical History | |
| Höhn et al. | The response of the rabbit's endometrium to uterine implants of progesterone and other steroids | |
| Ringler | Efficacy of topically applied progestational agents | |
| US3506763A (en) | Method of promoting growth of animals with testololactones | |
| Stern et al. | No effect of neonatal estrogenic stimulation or hypophysectomy on spontaneous activity in female rats. | |
| Forbes | Progesterone, 16a-Hydroxy-Progesterone, and Maintenance of Pregnancy In Mice. |